FI924934A0 - Nya ftalaziner som innehaoller en eter- eller tioetergruppering i 1-staellning och foerfarande foer deras framstaellning - Google Patents

Nya ftalaziner som innehaoller en eter- eller tioetergruppering i 1-staellning och foerfarande foer deras framstaellning

Info

Publication number
FI924934A0
FI924934A0 FI924934A FI924934A FI924934A0 FI 924934 A0 FI924934 A0 FI 924934A0 FI 924934 A FI924934 A FI 924934A FI 924934 A FI924934 A FI 924934A FI 924934 A0 FI924934 A0 FI 924934A0
Authority
FI
Finland
Prior art keywords
radical
substituted
phenyl
alkyl
phthalaziner
Prior art date
Application number
FI924934A
Other languages
English (en)
Other versions
FI924934A (fi
Inventor
Gerhard Scheffler
Ilona Fleischhauer
Bernhard Kutscher
Juergen Engel
Stefan Szelenyi
Ulrich Werner
Original Assignee
Asta Medical Aktiengesellschaf
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Asta Medical Aktiengesellschaf filed Critical Asta Medical Aktiengesellschaf
Publication of FI924934A0 publication Critical patent/FI924934A0/fi
Publication of FI924934A publication Critical patent/FI924934A/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D237/00—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
    • C07D237/26—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings condensed with carbocyclic rings or ring systems
    • C07D237/30—Phthalazines
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D237/00—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
    • C07D237/26—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings condensed with carbocyclic rings or ring systems
    • C07D237/30—Phthalazines
    • C07D237/32—Phthalazines with oxygen atoms directly attached to carbon atoms of the nitrogen-containing ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D453/00—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids
    • C07D453/02—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing not further condensed quinuclidine ring systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pain & Pain Management (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Cosmetics (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
FI924934A 1991-10-31 1992-10-30 Nya ftalaziner som innehaoller en eter- eller tioetergruppering i 1-staellning och foerfarande foer deras framstaellning FI924934A (fi)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4135910 1991-10-31

Publications (2)

Publication Number Publication Date
FI924934A0 true FI924934A0 (fi) 1992-10-30
FI924934A FI924934A (fi) 1993-05-01

Family

ID=6443832

Family Applications (1)

Application Number Title Priority Date Filing Date
FI924934A FI924934A (fi) 1991-10-31 1992-10-30 Nya ftalaziner som innehaoller en eter- eller tioetergruppering i 1-staellning och foerfarande foer deras framstaellning

Country Status (20)

Country Link
US (1) US5354750A (fi)
EP (1) EP0539805B1 (fi)
JP (1) JPH05222002A (fi)
KR (1) KR930007914A (fi)
CN (1) CN1071916A (fi)
AT (1) ATE157656T1 (fi)
AU (1) AU660726B2 (fi)
BR (1) BR9204187A (fi)
CA (1) CA2081819A1 (fi)
DE (2) DE4234933A1 (fi)
DK (1) DK0539805T3 (fi)
ES (1) ES2108066T3 (fi)
FI (1) FI924934A (fi)
GR (1) GR3025141T3 (fi)
HU (2) HUT62866A (fi)
IL (1) IL103601A0 (fi)
MX (1) MX9206245A (fi)
NO (1) NO924166L (fi)
TW (1) TW211563B (fi)
ZA (1) ZA928420B (fi)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9226573D0 (en) * 1992-12-21 1993-02-17 Ici Plc Heterocyclic compounds
US6426415B1 (en) 1997-09-03 2002-07-30 Guilford Pharmaceuticals Inc. Alkoxy-substituted compounds, methods and compositions for inhibiting parp activity
US20020028813A1 (en) * 1997-09-03 2002-03-07 Paul F. Jackson Thioalkyl compounds, methods, and compositions for inhibiting parp activity
US6635642B1 (en) 1997-09-03 2003-10-21 Guilford Pharmaceuticals Inc. PARP inhibitors, pharmaceutical compositions comprising same, and methods of using same
US6346536B1 (en) 1997-09-03 2002-02-12 Guilford Pharmaceuticals Inc. Poly(ADP-ribose) polymerase inhibitors and method for treating neural or cardiovascular tissue damage using the same
US6291425B1 (en) 1999-09-01 2001-09-18 Guilford Pharmaceuticals Inc. Compounds, methods and pharmaceutical compositions for treating cellular damage, such as neural or cardiovascular tissue damage
US6514983B1 (en) 1997-09-03 2003-02-04 Guilford Pharmaceuticals Inc. Compounds, methods and pharmaceutical compositions for treating neural or cardiovascular tissue damage
US6197785B1 (en) 1997-09-03 2001-03-06 Guilford Pharmaceuticals Inc. Alkoxy-substituted compounds, methods, and compositions for inhibiting PARP activity
US6395749B1 (en) 1998-05-15 2002-05-28 Guilford Pharmaceuticals Inc. Carboxamide compounds, methods, and compositions for inhibiting PARP activity
US6387902B1 (en) 1998-12-31 2002-05-14 Guilford Pharmaceuticals, Inc. Phenazine compounds, methods and pharmaceutical compositions for inhibiting PARP
US6723733B2 (en) 2000-05-19 2004-04-20 Guilford Pharmaceuticals, Inc. Sulfonamide and carbamide derivatives of 6(5H)phenanthridinones and their uses
WO2002044157A2 (en) * 2000-12-01 2002-06-06 Iconix Pharmaceuticals, Inc. Parb inhibitors
GB0507298D0 (en) 2005-04-11 2005-05-18 Novartis Ag Organic compounds

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2484029A (en) * 1945-12-21 1949-10-11 Ciba Pharm Prod Inc Hydrazine derivatives of pyridazine compounds
US3882119A (en) * 1970-01-27 1975-05-06 Lepetit Spa Tetracyclic substituted phthalazine compounds
IL48319A0 (en) * 1974-10-26 1975-12-31 Merck Patent Gmbh Araliphatic nitrogen compounds and a process for their preparation
JPH01261386A (ja) * 1988-04-11 1989-10-18 Nisshin Flour Milling Co Ltd 新規な２―ピリジルメチルチオ誘導体及びそれを含有する抗潰瘍剤

Also Published As

Publication number Publication date
IL103601A0 (en) 1993-03-15
US5354750A (en) 1994-10-11
JPH05222002A (ja) 1993-08-31
ES2108066T3 (es) 1997-12-16
CN1071916A (zh) 1993-05-12
HUT62866A (en) 1993-06-28
AU2747192A (en) 1993-05-06
TW211563B (fi) 1993-08-21
DE4234933A1 (de) 1993-05-06
MX9206245A (es) 1993-05-01
AU660726B2 (en) 1995-07-06
HU211863A9 (en) 1995-12-28
FI924934A (fi) 1993-05-01
ATE157656T1 (de) 1997-09-15
DE59208852D1 (de) 1997-10-09
HU9203431D0 (en) 1993-01-28
BR9204187A (pt) 1993-05-04
NO924166D0 (no) 1992-10-29
EP0539805A1 (de) 1993-05-05
CA2081819A1 (en) 1993-05-01
EP0539805B1 (de) 1997-09-03
KR930007914A (ko) 1993-05-20
DK0539805T3 (da) 1998-03-23
GR3025141T3 (en) 1998-02-27
ZA928420B (en) 1993-05-14
NO924166L (no) 1993-05-03

Similar Documents

Publication Publication Date Title
FI930970A0 (fi) Imidazolderivat med bifenylsulfonylurea- eller bifenylsulfonyluretansidokedja, foerfaranden foer framstaellning av dessa och anvaendning av dessa
FI924934A0 (fi) Nya ftalaziner som innehaoller en eter- eller tioetergruppering i 1-staellning och foerfarande foer deras framstaellning
FI884350A (fi) Som antagonister nyttiga nya benzimidazolin-2-oxo-1-karboxylsyraderivat av 5-ht reseptor.
DK0580502T3 (da) 3-(hydroxybenzylidenyl)-indolin-2-oner og farmaceutiske sammensætninger indeholdende disse
DK0641325T3 (da) Inhibitorer af retroviral protease
DE69527072D1 (de) Endothelin antagoniste
NO166129C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive tetrahydro-9h-pyrido (3,4-b)indoler.
DK0795334T3 (da) Nye prodrugs til behandling af tumorer og betændelsessygdomme
AU2734892A (en) Quinoline derivatives, process for their preparation, and their therapeutic applications
DE69309454D1 (de) Pyridincarboximidamide und deren anwendung
FI923774A (fi) 1,7-anellerade 2-(piperazinoalkyl)indolderivat samt foerfaranden och mellanprodukter foer deras framstaellning
FI921340A0 (fi) Nya tiazolidinon- och oxazolidinon- derivat, deras framstaellning och anvaendning som utvidgare av blod- kaerlen.
NO162234C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive pyridinkarboksylsyreestere.
DK0387489T3 (da) Anvendelse af 2,2,6,6-tetramethyl-4-aminopiperidinamider som fungicider
ATE15045T1 (de) Cephalosporinderivate, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische praeparate.
KR970706280A (ko) 5-HT1A 길항제로서의 비사이클릭 카복스아미드(Bicyclic carboxamides as 5-HT1 antagonists)
FI865057A0 (fi) Nya fluorhaltiga 1,4-dihydropyridiner, foerfarande foer deras framstaellning och deras anvaendning som laekemedel.
FI894125A (fi) Analogiamenetelmä terapeuttisesti käyttökelpoisen 3-piperidinyyli-indatsolin valmistamiseksi
DK0822192T3 (da) Nye inhibitorer af beta-blucuronidase

Legal Events

Date Code Title Description
FD Application lapsed